D-Ala.sup.5 -somatostatin and intermediates thereto
US4062816A · kind A · utility
7Cited by
1References
9Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Mar 11, 1976 |
| Grant date | Dec 13, 1977 |
| Priority date | — |
| Expiry date | Mar 11, 1996 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S930/28
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The tetradecapeptide ##STR1## is described along with corresponding non-toxic pharmaceutically-acceptable acid addition salts as well as intermediates useful in the synthesis of the tetradecapeptide. This tetradecapeptide as well as its pharmaceutically acceptable acid addition salts inhibit the secretion of gastric acid.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.